Stay updated on Cabozantinib in Advanced Adrenocortical Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Advanced Adrenocortical Carcinoma Clinical Trial page.

Latest updates to the Cabozantinib in Advanced Adrenocortical Carcinoma Clinical Trial page
- Check4 days agoChange DetectedThe page updated from v3.0.1 to v3.0.2 and removed the 'Back to Top' element, indicating a minor revision with no evident core-content changes.SummaryDifference0.2%
- Check11 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%
- Check18 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, as well as new related topics on adrenal gland cancer, while several previous terms and drug information have been removed.SummaryDifference3%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.4%
- Check39 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check47 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.9%
Stay in the know with updates to Cabozantinib in Advanced Adrenocortical Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Advanced Adrenocortical Carcinoma Clinical Trial page.